Note: the documents on this web site are PDF files. If you do not have a PDF reader, you can download one now.

Product name Product type Date released
Expand Hemlibra PI 27 May 2022
 
Expand Hemlibra CMI 27 May 2022
 
Hemlibra is used for routine prophylaxis in children, adolescents and adults with haemophilia A. This means it prevents bleeding or reduces the number of bleeding episodes. Hemlibra can be used for routine prophylaxis whether or not you have inhibitors to factor VIII.
Hemlibra contains the active substance emicizumab. This belongs to a group of medicines called monoclonal antibodies. Monoclonal antibodies are a type of protein that recognises and binds to a target in the body.
Haemophilia A is a bleeding condition present at birth, which is caused by missing or faulty factor VIII. Factor VIII is a blood clotting protein and blood does not clot normally when factor VIII is missing or not working properly.
Inhibitors to factor VIII develop in some people with haemophilia A after repeated use of factor VIII to prevent or treat bleeding. Inhibitors stop replacement factor VIII from working.
Hemlibra works like factor VIII, by binding to the same clotting factors, which helps your blood to clot. However, because emicizumab is different to factor VIII, it works whether or not inhibitors are present.
This medicine is used to prevent bleeding or reduce the number of bleeding episodes in people with haemophilia A (“routine prophylaxis”). It is not to be used "on-demand" to treat bleeds once they occur.
Ask your doctor if you have any questions about why this medicine has been prescribed for you.
This medicine is available only with a doctor's prescription.
This medicine is not expected to affect your ability to drive a car or operate machinery.
read more
Expand Xalamol 50/5 PI 27 May 2022
 
Expand Xalamol 50/5 CMI 27 May 2022
 
XALAMOL 50/5 is used to lower raised pressure in the eye and to treat glaucoma. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure.
Glaucoma is usually caused by a buildup of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye.
There are usually no symptoms of glaucoma. If glaucoma is not treated it can lead to serious problems, including total blindness. In fact, untreated glaucoma is one of the most common causes of blindness.
XALAMOL 50/5 is made up of 2 active ingredients, latanoprost and timolol maleate. Latanoprost works by allowing more fluid to flow out from within your eye(s). Timolol maleate lowers the pressure in the eye by reducing the production of fluid.
Latanoprost belongs to a family of medicines called prostaglandin agonists. Timolol maleate belongs to a family of medicines called beta- blockers.
Although XALAMOL 50/5 helps control your glaucoma it does not cure it. You must keep using it until your doctor tells you to stop.
Ask your doctor if you have any questions about why XALAMOL 50/5 has been prescribed for you.
Your doctor may have prescribed it for another reason.
XALAMOL 50/5 is not recommended for use in children.
The safety and effectiveness of XALAMOL 50/5 in children has not been established.
read more
Expand Tamiflu CMI 27 May 2022
 
Do not use if you have ever had an allergic reaction to Tamiflu or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use Tamiflu? in the full CMI.
read more
Expand Amgevita PI 27 May 2022
 
Expand Rinvoq PI 26 May 2022
 
Expand Esmeron CMI 26 May 2022
 
Do not use if you have ever had an allergic reaction to Esmeron or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use Esmeron? in the full CMI.
read more
Expand Esmeron PI 26 May 2022
 
Expand Erlyand CMI 26 May 2022
 
ERLYAND is an anticancer medicine that contains the active substance apalutamide.
ERLYAND is used to treat patients with:
prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.
prostate cancer that has spread to other parts of the body and still responds to treatments that lower testosterone
ERLYAND belongs to a group of medicines called androgen receptor inhibitors.
Ask your doctor or healthcare professional if you have any questions about why ERLYAND has been prescribed for you.
This medicine is available only with a doctor's prescription.
Before you take ERLYAND

When you must not use it:

Do not take ERLYAND:
if you are allergic (hypersensitive) to apalutamide, or other ingredients of ERLYAND. See Product Description at the end of this leaflet for a list of ingredients.
Do not take ERLYAND:
if the packaging is torn or shows signs of tampering.
if the expiry date (month and year) printed on the pack has passed. If you take ERLYAND after the expiry date it may not work.
Do not take ERLYAND if you are pregnant or maybe potentially pregnant.
ERLYAND is not for use in women and children.
ERLYAND may harm your unborn baby.
Do not father a child while taking ERLYAND and for 3 months after stopping treatment.
Use condoms and do not donate sperm during treatment and for 3 months after your treatment has finished. Talk with your healthcare provider if you have questions about birth control. If you plan to father a child, talk to your doctor or healthcare professional before taking ERLYAND.
ERLYAND should not be used by anyone under 18 years of age because it has not been studied in this age group.

Before you start to use it:

Tell your doctor if you have or have had any medical conditions, especially the following:
have a history of seizures, brain injury, stroke, or brain tumours (non-cancerous or cancerous)
have a history of heart disease
you have any other medical condition

Taking other medicines:

Tell your doctor if you take any of the following medicines:
warfarin, a medicine used to prevent blood clots
omeprazole, a medicine to treat heartburn or gastric and duodenal ulcers
midazolam, often used as a sedative
rosuvastatin or gemfibrozil, medicines used to lower your lipid levels
fexofenadine, a medicine used to treat hay fever
rifampin, a medicine used to treat certain infections
antifungal medicines like itraconazole or ketoconazole
ERLYAND might interact with other medicines. This may result in greater or lesser effects or even side effects from these medicines.
Tell your doctor if you are taking any other medicines, including medicines you can buy without a prescription from a pharmacy, supermarket or health food shop.
Your doctor can tell you whether you can continue the medicines you are taking or need to reduce the dose.
read more
Expand Braltus PI 26 May 2022
 
Expand Braltus CMI 26 May 2022
 
Do not use if you have ever had an allergic reaction to tiotropium, atropine, medicines like atropine (e.g. ipratropium or oxitropium) or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use BRALTUS? in the full CMI.
read more
Expand Rimycin CMI 26 May 2022
 
Do not take RIMYCIN if you have ever had an allergic reaction to RIMYCIN or any of the ingredients listed at the end of the CMI.
Do not take RIMYCIN if you have jaundice.
Do not take RIMYCIN if you are taking saquinavir or ritonavir. These are medicines used to treat AIDS and HIV.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding or planning to breastfeed.
For more information, see Section 2. What should I know before I take RIMYCIN? in the full CMI.
read more
Expand Rimycin PI 26 May 2022
 
Expand DBL Amikacin Injection PI 26 May 2022
 
Expand DBL Leucovorin Calcium Injection and Tablets PI 25 May 2022
 
Expand Alunbrig PI 24 May 2022
 
Expand Tremfya CMI 23 May 2022
 
TREMFYA contains the active substance guselkumab which is a type of protein called a monoclonal antibody. This medicine works by neutralising the activity of a protein called IL-23, which is present in increased levels in people with psoriasis.
TREMFYA is used to treat:
adults with moderate to severe plaque psoriasis, an inflammatory condition affecting the skin and nails. TREMFYA can improve skin clearance and nail appearance and reduce symptoms of psoriasis, such as scaling, shedding, flaking, itching, pain, and burning.
adults with active psoriatic arthritis, an inflammatory disease of the joints in which psoriasis usually occurs in association with arthritis. If you have active psoriatic arthritis, you will be given TREMFYA alone or in combination with a conventional Disease Modifying Anti-Rheumatic Drug (DMARD) such as methotrexate.
Ask your doctor if you have any questions about why TREMFYA has been prescribed for you.
Your doctor may have prescribed TREMFYA for another reason.
read more
Expand Alepam CMI 20 May 2022
 
ALEPAM is used for:
anxiety, such as the anxiety associated with depression
tremor, anxiety and confusion associated with alcohol withdrawal.
ALEPAM contains the active ingredient oxazepam, which belongs to a group of medicines called benzodiazepines. These medicines are thought to work by their action on brain chemicals.
Ask your doctor if you have any questions about why ALEPAM has been prescribed for you.
Your doctor may have prescribed ALEPAM for another reason.
In general, benzodiazepines such as ALEPAM should be taken for short periods only (for example 2 to 4 weeks). Continuous long term use is not recommended unless advised by your doctor. The use of benzodiazepines may lead to dependence on the medicine.
ALEPAM is not recommended for use in children under 16 years of age, as its safety and effectiveness have not been established in this age group.
ALEPAM is available only with a doctor's prescription.
read more
Expand Alepam PI 20 May 2022